Concepedia

Zhigang Li

ZL

Statistics

Publications

112

Citations

6.3K

H-Index

38

Active since

2001

Affiliations

Shanghai Chest Hospital(Current)

Shanghai Jiao Tong University

Second Military Medical University

Fudan University

Changhai Hospital

Zhigang Li is an author at Shanghai Chest Hospital specializing in medicine, oncology, and esophageal cancer.

ORCID

Publications per year

2001–2025

112

Publications

112

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun, Lin Shen, Manish A. Shah et al. · The Lancet · 2021 · 1.6K citations · Full text

, , +14

Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Jun Liu, Yang Yang, Zhichao Liu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 278 citations · Full text

, , +14

IQGAP1 Promotes Cell Motility and Invasion

Jennifer Mataraza, Michael W. Briggs, Zhigang Li et al. · Journal of Biological Chemistry · 2003 · 207 citations · Full text

, , +10

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 196 citations · Full text

, , +14

Robot-assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma

Yang Yang, Bin Li, Jun Yi et al. · Annals of Surgery · 2021 · 194 citations

, , +15

1–5 of 112